AU Patent

AU2020402049B2 — Preparation of Trifarotene and intermediates and polymorphs thereof

Assigned to Taro Pharmaceutical Industries Ltd · Expires 2023-06-01 · 3y expired

What this patent protects

The present disclosure provides a process for the preparation of Trifarotene. The disclosure also provides novel intermediates in the process described herein. Also provided are novel polymorphs of Trifarotene.

USPTO Abstract

The present disclosure provides a process for the preparation of Trifarotene. The disclosure also provides novel intermediates in the process described herein. Also provided are novel polymorphs of Trifarotene.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020402049B2
Jurisdiction
AU
Classification
—
Expires
2023-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Taro Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.